MTOR and renal cell carcinoma: Then, in the RCC mouse model, RAC extract downregulated the phosphorylation of PI3K, Akt, mTOR, P38, and ERK, which further demonstrated that RAC might exhibit anti-RCC effect by suppressing the PI3K/AKT/mTOR and MAPK pathway.